evidencegaps
Primary study · included by 1 review

Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients.

Hollingsworth 2016 · Hollingsworth Brynn, Senter Leigha, Zhang Xiaoli, et al. · The Journal of clinical endocrinology and metabolism · 2016

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Hollingsworth 2016 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Sialadenitis (pooled prevalence)
Radioiodine (I131) therapy · more than 1 year after RIT
Prevalence 0.24 [0.21, 0.29]3 studies · 405 participantsGRADE not reported

1 including review in total.